Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) EPS (Weighted Average and Diluted): 2020-2023

Historic EPS (Weighted Average and Diluted) for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$1.88.

  • Immuneering's EPS (Weighted Average and Diluted) fell 4.00% to -$0.52 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.89, marking a year-over-year increase of 1.56%. This contributed to the annual value of -$1.88 for FY2023, which is 1.57% up from last year.
  • As of FY2023, Immuneering's EPS (Weighted Average and Diluted) stood at -$1.88, which was up 1.57% from -$1.91 recorded in FY2022.
  • Immuneering's EPS (Weighted Average and Diluted)'s 5-year high stood at -$1.88 during FY2023, with a 5-year trough of -$3.44 in FY2020.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$2.08, with a median of -$1.91 in 2022.
  • Data for Immuneering's EPS (Weighted Average and Diluted) shows a peak YoY climbed of 28.49% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Immuneering's EPS (Weighted Average and Diluted) stood at -$3.44 in 2020, then increased by 28.49% to -$2.46 in 2021, then increased by 22.36% to -$1.91 in 2022, then grew by 1.57% to -$1.88 in 2023.